YCYicheng Chen

Yicheng Chen

*This is an algorithmically generated author record based on publicly available information.

Yicheng Chen has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Simin Zhu

    College of Life Sciences

    3 shared publications
  • Yufan Zhang

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology

    3 shared publications
  • Fuwei Liu

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration National Clinical Research Center for Oral Diseases Shaanxi Clinical Research Center for Oral Diseases Department of Oral and Maxillofacial Surgery School of Stomatology The Fourth Military Medical University Xi'an 710032 China

    2 shared publications
  • He Xin

    The 900th Hospital of Joint Logistic Support Force, PLA Fuzhou Fujian 350001 P. R. China

    2 shared publications
  • Wenhui Zhang

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology

    2 shared publications
  • Xiao Zhang

    College of Life Sciences

    2 shared publications

Latest Publications

  • Open Access

    RNA Coating Promotes Peri-Implant Osseointegration

    by Xiao Zhang, Yicheng Chen, Shanluo Zhou, Ya Liu, Simin Zhu, Xuelian Jia, Zihan Lu, Yufan Zhang, Wenhui Zhang, Zhou Ye, et al.

    In addition to transmitting and carrying genetic information, RNA plays an important abiotic role in the world of nanomaterials. RNA is a natural polyanionic biomacromolecule, and its ability to promote osteogenesis by binding with other inorganic materials as an osteogenic induction agent was discovered only recently. However, whether it can promote osseointegration on implants has not been reported. Here, we investigated the effect of the RNA-containing coating materials on peri-implant osseointegration. Total RNA extracted from rat muscle tissue was used as an osteogenic induction agent, and hyaluronic acid (HA) was used to maintain its negative charge. In simulated body fluids (SBF), in vitro studies demonstrated that the resulting material encouraged calcium salt deposition. Cytological experiments showed that the RNA-containing coating induced greater cell adhesion and osteogenic differentiation in comparison to the control. The results of animal experiments showed that the RNA-containing coating had osteoinductive and bone conduction activities, which are beneficial for bone formation and osseointegration. Therefore, the RNA-containing coatings are useful for the surface modification of titanium implants to promote osseointegration.


  • Open Access

    Phospholipid‐Modified Titanium Surface‐Loaded Apoptotic Extracellular Vesicles Promote Early Angiogenesis and Improve Implant Osseointegration Through Immune Regulation

    by Yicheng Chen, Xiaona Ning, Simin Zhu, He Xin, Xiaomin Ren, Pei Wang, Yu Zhang, Yufan Zhang, Yijing Chen, Yunpeng Li, et al.

    Tissue‐engineered extraction products, such as apoptotic extracellular vesicles (ApoEVs), significantly promote tissue regeneration, endowing them with the potential to improve osseointegration. However, there is an urgent need to determine how to effectively load these materials onto a material surface to maximize their function. Considering that all such products have a phospholipid bilayer, a phospholipid‐modified implant coating is designed that can effectively load tissue‐engineered products with a phospholipid bilayer structure. ApoEVs are effectively loaded onto the surface and the osteogenic effect improved, achieving good osseointegration. In vitro experiments show that this material improves angiogenesis by promoting macrophage M1 polarization and NO secretion in the early stages. In vivo experiments show that after implantation, it effectively improve the peri‐implant vascularization of the implant, thereby improving the new bone formation ability and osseointegration. This study provides a universal solution for loading vesicular tissue‐engineered products onto an implant surface and validates its ability to improve bone fusion using ApoEVs as an example while exploring its mechanism.


  • Hydrophobic Coating Platforms for High‐Efficiency Loading and Direct Transmembrane Delivery of Fat‐Soluble Osteogenic Drug for Enhanced Osseointegration of Titanium Implants

    by Yicheng Chen, Xiaona Ning, Xuelian Jia, He Xin, Shaolingzhuo Kong, Ben Wu, Tiexin Ding, Simin Zhu, Xiaomin Ren, Xiao Zhang, et al.

    Compared with water‐soluble osteogenic drugs, fat‐soluble osteogenic drugs exhibit higher bioavailability and drug stability, making them valuable for enhancing the osseointegration of implants. However, existing drug‐loading coatings are primarily designed for water‐soluble drugs, limiting their effectiveness in loading and delivering fat‐soluble osteogenic drugs. This study employed alkali treatment, silanization, and oleic acid acylation to sequentially modify the surface of Ti alloy, aiming to fabricate surfaces capable of efficiently loading and delivering fat‐soluble osteogenic drugs. Results show that the hydrophilicity and loading capacity of fat‐soluble osteogenic drugs strongly depended on the duration of the acylation treatment. Furthermore, the drug release mechanism involved direct diffusion from the coating to the cells in contact, resulting in improved bioavailability, as opposed to diffusion into the surrounding medium and subsequent cellular uptake. In vitro experiments using vitamine D3 (VD3) as a model drug confirmed that the coating effectively promoted bone formation through the highly efficient delivery of VD3. Furthermore, in vivo experiments demonstrated that the VD3‐loaded lipophilic surface significantly enhanced osteogenic capability and improved the osseointegration of titanium implants. This study provides a promising strategy for loading fat‐soluble drugs onto Ti implants and direct experimental evidence demonstrating the significant value of fat‐soluble drugs in promoting implant osseointegration.